Summary
Updated Aug 31, 2026
Kurt von Emster is Director of Jasper Therapeutics, Inc. (JSPR). 2 SEC Form 4 filings on record going back to 2025, most recently on 4 August 2026.
Trading Pattern
InsiderAlpha's records for Kurt von Emster go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kurt von Emster files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ron Martell - $100K of JSPR open-market activity in the last 12 months
- Thomas G. Wiggans - $100K of JSPR open-market activity in the last 12 months
- Judith Anne Shizuru - $100K of JSPR open-market activity in the last 12 months
- Svetlana Lucas - $49K of JSPR open-market activity in the last 12 months
- Patrick J. Crutcher - of JSPR open-market activity in the last 12 months
- Matthew E. Ros - of JSPR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kurt von Emster?
Kurt von Emster is a corporate insider, tracked as Director of Jasper Therapeutics, Inc. (JSPR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kurt von Emster submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Kurt von Emster's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kurt von Emster and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial